Dexmedetomidine alleviates acute lung injury by promoting Tregs differentiation via activation of AMPK/SIRT1 pathway

[1]  Jingli Lu,et al.  Metabolic Controls on Epigenetic Reprogramming in Regulatory T Cells , 2021, Frontiers in Immunology.

[2]  N. Meyer,et al.  Acute respiratory distress syndrome , 2021, The Lancet.

[3]  Si-tao Li,et al.  Melatonin-induced lncRNA LINC01512 prevents Treg/Th17 imbalance by promoting SIRT1 expression in necrotizing enterocolitis. , 2021, International immunopharmacology.

[4]  M. Braun.  The Natural History of T Cell Metabolism , 2021, International journal of molecular sciences.

[5]  Yongsheng Fan,et al.  Metabolic Disturbance and Th17/Treg Imbalance Are Associated With Progression of Gingivitis , 2021, Frontiers in Immunology.

[6]  Anmin Hu,et al.  Comparative Effectiveness of Midazolam, Propofol, and Dexmedetomidine in Patients With or at Risk for Acute Respiratory Distress Syndrome: A Propensity Score-Matched Cohort Study , 2021, Frontiers in Pharmacology.

[7]  Yuan Zhang,et al.  Dexmedetomidine ameliorates endotoxin-induced acute lung injury in vivo and in vitro by preserving mitochondrial dynamic equilibrium through the HIF-1a/HO-1 signaling pathway , 2021, Redox biology.

[8]  Chuanjiang Wang,et al.  Luteolin Regulates the Differentiation of Regulatory T Cells and Activates IL-10-Dependent Macrophage Polarization against Acute Lung Injury , 2021, Journal of immunology research.

[9]  Zhen Bian,et al.  Effect of dexmedetomidine on CD4+ T cells and programmed cell death protein-1 in postoperative analgesia: a prospective, randomized, controlled study. , 2021, Minerva Anestesiologica.

[10]  Jing Xu,et al.  Dexmedetomidine alleviates pulmonary edema through the epithelial sodium channel (ENaC) via the PI3K/Akt/Nedd4-2 pathway in LPS-induced acute lung injury , 2020, Immunologic Research.

[11]  L. Ware,et al.  Biomarkers in acute respiratory distress syndrome. , 2020, Current opinion in critical care.

[12]  J. Payen,et al.  Analgesia and sedation in patients with ARDS , 2020, Intensive Care Medicine.

[13]  Z. Meng,et al.  Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art , 2020, Frontiers in Immunology.

[14]  D. Brenner,et al.  Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer , 2020, European journal of immunology.

[15]  J. Mock,et al.  Impact of Regulatory T Cells on Type 2 Alveolar Epithelial Cell Transcriptomes during Resolution of Acute Lung Injury and Contributions of IFN-γ , 2020, American Journal of Respiratory Cell and Molecular Biology.

[16]  S. Sakaguchi,et al.  New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression. , 2020, Current opinion in immunology.

[17]  C. Piccirillo.  Transcriptional and translational control of Foxp3+ regulatory T cell functional adaptation to inflammation. , 2020, Current opinion in immunology.

[18]  Huan Luo,et al.  Dexmedetomidine Ameliorates Renal Ischemia Reperfusion-Mediated Activation of the NLRP3 Inflammasome in Alveolar Macrophages. , 2020, Gene.

[19]  S. Bergese,et al.  Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial , 2020, The Lancet.

[20]  Zhongheng Zhang,et al.  Dexmedetomidine For The Treatment Of Acute Lung Injury: A Fact Or Fiction? , 2020, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[21]  Si-tao Li,et al.  Melatonin ameliorates necrotizing enterocolitis by preventing Th17/Treg imbalance through activation of the AMPK/SIRT1 pathway , 2020, Theranostics.

[22]  V. Singh,et al.  Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation , 2020, Inflammation.

[23]  S. Sakaguchi,et al.  Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases , 2020, Cell Research.

[24]  Wenxian Fu,et al.  Transcriptional regulation of Treg homeostasis and functional specification , 2020, Cellular and Molecular Life Sciences.

[25]  Stefano Volpi,et al.  On the Alert for Cytokine Storm: Immunopathology in COVID‐19 , 2020, Arthritis & rheumatology.

[26]  Amber Dance.  What is a cytokine storm? , 2020 .

[27]  D. Koestler,et al.  Coexpression of FOXP3 and a Helios isoform enhances the effectiveness of human engineered regulatory T cells. , 2020, Blood advances.

[28]  Kiran Shekar,et al.  Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases , 2020, The Lancet Respiratory Medicine.

[29]  M. Matthay,et al.  Treatment for severe acute respiratory distress syndrome from COVID-19 , 2020, The Lancet Respiratory Medicine.

[30]  A. Nadeem,et al.  Blockade of interleukin-2-inducible T-cell kinase signaling attenuates acute lung injury in mice through adjustment of pulmonary Th17/Treg immune responses and reduction of oxidative stress. , 2020, International immunopharmacology.

[31]  B. Kobilka,et al.  Activation of the α2B adrenoceptor by the sedative sympatholytic dexmedetomidine , 2020, Nature Chemical Biology.

[32]  M. Matthay,et al.  Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome. , 2020, American journal of respiratory cell and molecular biology.

[33]  Yuchen Ge,et al.  SIRT1 and aging related signaling pathways , 2020, Mechanisms of Ageing and Development.

[34]  Chuanjiang Wang,et al.  Curcumin regulates the differentiation of naïve CD4+T cells and activates IL-10 immune modulation against acute lung injury in mice. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  R. Hentschel,et al.  Surfactant replacement therapy: from biological basis to current clinical practice , 2020, Pediatric Research.

[36]  Z. Xia,et al.  Protective Effect of Dexmedetomidine on Acute Lung Injury via the Upregulation of Tumour Necrosis Factor-α-Induced Protein-8-like 2 in Septic Mice , 2020, Inflammation.

[37]  J. Rouby,et al.  T regulatory cells activation and distribution are modified in critically ill patients with acute respiratory distress syndrome: a prospective single-centre observational study. , 2020, Anaesthesia, critical care & pain medicine.

[38]  E. Shevach,et al.  Helios: still behind the clouds , 2019, Immunology.

[39]  Xiaomin Song,et al.  Foxp3 Post-translational Modifications and Treg Suppressive Activity , 2019, Front. Immunol..

[40]  A. Ribas,et al.  Tumour-intrinsic resistance to immune checkpoint blockade , 2019, Nature Reviews Immunology.

[41]  C. Traube,et al.  Sedation strategies in children with pediatric acute respiratory distress syndrome (PARDS). , 2019, Annals of translational medicine.

[42]  N. Yang,et al.  Dexmedetomidine inhibits apoptosis and expression of COX-2 induced by lipopolysaccharide in primary human alveolar epithelial type 2 cells. , 2019, Biochemical and biophysical research communications.

[43]  D. Kouvelas,et al.  Dexmedetomidine effects in different experimental sepsis in vivo models. , 2019, European journal of pharmacology.

[44]  Jian-zhou Liu,et al.  Regulatory T‐cells promote pulmonary repair by modulating T helper cell immune responses in lipopolysaccharide‐induced acute respiratory distress syndrome , 2019, Immunology.

[45]  J. Mock,et al.  Transcriptional analysis of Foxp3+ Tregs and functions of two identified molecules during resolution of ALI. , 2019, JCI insight.

[46]  A. Randolph,et al.  The acute respiratory distress syndrome. , 1996, New England Journal of Medicine.

[47]  J. Christie,et al.  Acute Respiratory Distress Syndrome Phenotypes , 2019, Seminars in Respiratory and Critical Care Medicine.

[48]  S. Mehrotra,et al.  Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice. , 2019, Blood.

[49]  E. Shevach,et al.  Helios+ and Helios− Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoires , 2018, European journal of immunology.

[50]  Lingzhi Yu,et al.  Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury by targeting NLRP3 via miR‐381 , 2018, Journal of biochemical and molecular toxicology.

[51]  Zhi-bo Xiao,et al.  Regulatory T Cells and Acute Lung Injury: Cytokines, Uncontrolled Inflammation, and Therapeutic Implications , 2018, Front. Immunol..

[52]  Wei Zhao,et al.  Taurine enhances the protective effect of Dexmedetomidine on sepsis-induced acute lung injury via balancing the immunological system. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[53]  T. S. Ramasamy,et al.  Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming , 2018, Ageing Research Reviews.

[54]  Azeem Alam,et al.  Dexmedetomidine attenuates lung apoptosis induced by renal ischemia–reperfusion injury through α2AR/PI3K/Akt pathway , 2018, Journal of Translational Medicine.

[55]  Daniel Brodie,et al.  Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment , 2018, JAMA.

[56]  Q. Lv,et al.  Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD+/SIRT1/SUV39H1/H3K9me3 signaling pathway , 2018, Cell Death & Disease.

[57]  R. Shaw,et al.  AMPK: guardian of metabolism and mitochondrial homeostasis , 2017, Nature Reviews Molecular Cell Biology.

[58]  Arthur S Slutsky,et al.  T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10. , 2017, Blood.

[59]  O. Gajic,et al.  Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease? , 2017, American journal of respiratory and critical care medicine.

[60]  M. Struys,et al.  Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine , 2017, Clinical Pharmacokinetics.

[61]  Peng Kong,et al.  Methylene blue alleviates experimental autoimmune encephalomyelitis by modulating AMPK/SIRT1 signaling pathway and Th17/Treg immune response , 2016, Journal of Neuroimmunology.

[62]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[63]  T. Allen,et al.  Acute Lung Injury: A Clinical and Molecular Review. , 2016, Archives of pathology & laboratory medicine.

[64]  J. Marini.  Advances in the support of respiratory failure: putting all the evidence together , 2015, Critical Care.

[65]  L. King,et al.  Regulatory T cell DNA methyltransferase inhibition accelerates resolution of lung inflammation. , 2015, American journal of respiratory cell and molecular biology.

[66]  C. Elson,et al.  TGF‐β converts Th1 cells into Th17 cells through stimulation of Runx1 expression , 2015, European journal of immunology.

[67]  Yong Li,et al.  The ratio of Th17/Treg cells as a risk indicator in early acute respiratory distress syndrome , 2015, Critical Care.

[68]  F. Andris,et al.  AMPK in Lymphocyte Metabolism and Function , 2015, International reviews of immunology.

[69]  W. Mitzner,et al.  Foxp3+ Regulatory T Cells Promote Lung Epithelial Proliferation , 2014, Mucosal Immunology.

[70]  D. Pardoll,et al.  Treg functional stability and its responsiveness to the microenvironment , 2014, Immunological reviews.

[71]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[72]  I. Rahman,et al.  Redox regulation of SIRT1 in inflammation and cellular senescence. , 2013, Free radical biology & medicine.

[73]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[74]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[75]  Lin Bin.  FOXP3~+ regulatory T cells , 2010 .

[76]  P. Puigserver,et al.  AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity , 2009, Nature.

[77]  S. Yarkoni,et al.  Mechanisms of T regulatory cell function. , 2008, Autoimmunity reviews.

[78]  E. Chi,et al.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. , 2008, Immunity.

[79]  Erwan L'Her,et al.  [Acute respiratory distress]. , 2006, La Revue du praticien.

[80]  H. Obara,et al.  ONO-1714, a Nitric Oxide Synthase Inhibitor, Attenuates Endotoxin-Induced Acute Lung Injury in Rabbits , 2003, Anesthesia and analgesia.

[81]  D. Fowell.  in regulatory T-cell , 2022 .